It should be pointed out that some CRC patients in this study were treated with epidermal-growth-factor receptor (EGFR)-targeting antibody Cetuximab, which inhibits cancer proliferation and decreases Mg level as well (28). Here, EGFR is linked to colorectal carcinoma.